Blood processor
Latest Bristol-Myers Squibb Company Patents:
- Inhibitors of protein tyrosine phosphatase, compositions, and methods of use
- Aminotriazolopyridines as kinase inhibitors
- Use of alkaline washes during chromatography to remove impurities
- IONIZABLE LIPIDS
- METHODS OF CONTROLLING THE LEVEL OF DISSOLVED OXYGEN (DO) IN A SOLUTION COMPRISING A RECOMBINANT PROTEIN IN A STORAGE CONTAINER
Description
FIG. 1 is a front view of the blood processor of the present invention;
FIG. 2 is a side view of the blood processor of the present invention;
FIG. 3 is an top view of the blood processor of the present invention; and,
FIG. 4 is a perspective view of the blood processor of the present invention.
The bottom and rear views of the blood processor of the present invention are plain and unornamented.
The opposite side view to FIG. 2 of the blood processor is identical to that shown.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
D248488 | July 11, 1978 | Ashcraft et al. |
D258909 | April 14, 1981 | Bergo et al. |
D274751 | July 17, 1984 | Brown et al. |
D282578 | February 11, 1986 | Humphreys et al. |
D346027 | April 12, 1994 | Kobayashi |
D367534 | February 27, 1996 | DiPerna et al. |
4585436 | April 29, 1986 | Davis et al. |
4976851 | December 11, 1990 | Tanokura et al. |
5391142 | February 21, 1995 | Sites et al. |
5401237 | March 28, 1995 | Tachibana et al. |
5423738 | June 13, 1995 | Robinson et al. |
0654669 | May 1995 | EPX |
9714451 | April 1997 | WOX |
9720635 | June 1997 | WOX |
Patent History
Patent number: D420444
Type: Grant
Filed: Dec 7, 1995
Date of Patent: Feb 8, 2000
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Stella Reid
Attorneys: Theodore R. Furman, Jr., John M. Kilcoyne, Stuart E. Krieger
Application Number: 0/47,554
Type: Grant
Filed: Dec 7, 1995
Date of Patent: Feb 8, 2000
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Stella Reid
Attorneys: Theodore R. Furman, Jr., John M. Kilcoyne, Stuart E. Krieger
Application Number: 0/47,554
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)
International Classification: 2404;
International Classification: 2404;